Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats

José Vitor Mota Lemos, Joyce Ohana de Lima Martins, Larissa Carvalho Machado, Lara Rabelo Aragão, Maria Elisa Quezado Lima Verde, Cláudia do Ó. Pessoa, Maria Júlia Barbosa Bezerra, Ana Paula Negreiros Nunes Alves, Paulo Goberlânio de Barros Silva
{"title":"Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats","authors":"José Vitor Mota Lemos, Joyce Ohana de Lima Martins, Larissa Carvalho Machado, Lara Rabelo Aragão, Maria Elisa Quezado Lima Verde, Cláudia do Ó. Pessoa, Maria Júlia Barbosa Bezerra, Ana Paula Negreiros Nunes Alves, Paulo Goberlânio de Barros Silva","doi":"10.1016/j.oooo.2024.08.013","DOIUrl":null,"url":null,"abstract":"The study aimed to evaluate digoxin, an RORγt inhibitor, in Medication-Related Osteonecrosis of the Jaws (MRONJ) in male rats treated with zoledronic acid (ZA). Forty male Wistar rats were divided into a negative control group (0.1 mL/kg saline), a positive control group (ZA, 0.20 mg/kg), and three test groups treated with ZA and digoxin at 1 (DG1), 2 (DG2), or 4 (DG4) mg/kg. These groups received treatment three times weekly. ZA was administered intravenously on days 0, 7, and 14, followed by extraction of the left lower first molar on day 42, a final ZA dose on day 49, and euthanasia on day 70. Analyses included radiographic, histomorphometric, and immunohistochemical evaluation of the mandibles, western blotting of gingiva, and mechanical tests on femurs. Statistical analysis was performed using ANOVA/Bonferroni tests ( < .05). Digoxin reduced radiolucency of MRONJ ( < .001), inflammatory cells, empty osteocyte lacunae ( < .001), apoptotic osteoclasts ( < .001), and Caspase-3-positive osteocytes ( = .021). ZA increased immunoreactivity for most markers except c-Fos, while digoxin reduced interleukin 17, TNF-α, IL-6, IL-2, FOXP3, c-Jun, NFκB ( < .001), TGF-β ( = .009), RANKL ( = .035), and OPG ( = .034). Digoxin also reversed RORγt expression ( < .001), increased diarrhea scores ( = .028), renal and cardiac indexes ( < .001), and enhanced femur mechanical properties ( < .013). Digoxin attenuated MRONJ by inhibiting RORγt and reducing the Th17 response.","PeriodicalId":501075,"journal":{"name":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.oooo.2024.08.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The study aimed to evaluate digoxin, an RORγt inhibitor, in Medication-Related Osteonecrosis of the Jaws (MRONJ) in male rats treated with zoledronic acid (ZA). Forty male Wistar rats were divided into a negative control group (0.1 mL/kg saline), a positive control group (ZA, 0.20 mg/kg), and three test groups treated with ZA and digoxin at 1 (DG1), 2 (DG2), or 4 (DG4) mg/kg. These groups received treatment three times weekly. ZA was administered intravenously on days 0, 7, and 14, followed by extraction of the left lower first molar on day 42, a final ZA dose on day 49, and euthanasia on day 70. Analyses included radiographic, histomorphometric, and immunohistochemical evaluation of the mandibles, western blotting of gingiva, and mechanical tests on femurs. Statistical analysis was performed using ANOVA/Bonferroni tests ( < .05). Digoxin reduced radiolucency of MRONJ ( < .001), inflammatory cells, empty osteocyte lacunae ( < .001), apoptotic osteoclasts ( < .001), and Caspase-3-positive osteocytes ( = .021). ZA increased immunoreactivity for most markers except c-Fos, while digoxin reduced interleukin 17, TNF-α, IL-6, IL-2, FOXP3, c-Jun, NFκB ( < .001), TGF-β ( = .009), RANKL ( = .035), and OPG ( = .034). Digoxin also reversed RORγt expression ( < .001), increased diarrhea scores ( = .028), renal and cardiac indexes ( < .001), and enhanced femur mechanical properties ( < .013). Digoxin attenuated MRONJ by inhibiting RORγt and reducing the Th17 response.
地高辛通过 RORγt 依赖性 Th17 反应减轻雄性大鼠与双膦酸盐相关的颌骨坏死症
该研究旨在评估地高辛(一种RORγt抑制剂)对唑来膦酸(ZA)治疗雄性大鼠药物相关性颌骨坏死(MRONJ)的影响。40 只雄性 Wistar 大鼠被分为阴性对照组(0.1 毫升/千克生理盐水)、阳性对照组(ZA,0.20 毫克/千克)和三个试验组,试验组分别使用 1(DG1)、2(DG2)或 4(DG4)毫克/千克的ZA和地高辛进行治疗。这些试验组每周接受三次治疗。第0、7和14天静脉注射ZA,第42天拔除左下第一臼齿,第49天注射最后一次ZA,第70天安乐死。分析包括下颌骨的放射学、组织形态学和免疫组化评估、牙龈的印迹分析以及股骨的机械测试。统计分析采用方差分析/邦费罗尼检验(< .05)。地高辛减少了MRONJ的放射性透明(< .001)、炎症细胞、空骨细胞裂隙(< .001)、凋亡的破骨细胞(< .001)和Caspase-3阳性的骨细胞(= .021)。ZA增加了除c-Fos以外的大多数标记物的免疫活性,而地高辛则降低了白细胞介素17、TNF-α、IL-6、IL-2、FOXP3、c-Jun、NFκB(< .001)、TGF-β(= .009)、RANKL(= .035)和OPG(= .034)。地高辛还逆转了RORγt的表达(< .001),提高了腹泻评分(= .028)、肾脏和心脏指数(< .001),并增强了股骨的机械性能(< .013)。地高辛通过抑制RORγt和减少Th17反应减轻了MRONJ。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信